Raul Cordoba: e-PROMs in Lymphoma – Impact on Symptoms, Care Use, and Survival
Raul Cordoba, Head of the Lymphoma Unit at the Foundation Jimenez Diaz University Hospital, shared a post on X:
“HOT OFF THE PRESS!!
Effects of an Electronic Patient Reported Outcome Measures (e-PROMs) Program on Symptom Reporting, Use of Healthcare, and Overall Survival in Patients with Lymphoma: A Multicenter Prospective Study.
Low grade of agreement was met between adverse events collected by physicians and those reported by patients. The only categories where no differences were found (p > 0.05) were gastrointestinal (63% vs. 68%), neurological (29% vs. 31%), and respiratory (12% vs. 17%).
Pareto charts showing changes in PROMs domains at different timestamps during treatment (1, 3, and 6 months from start of treatment).
After a median follow-up of 19.1 months (IQR 11.5–26.3), median OS was significantly longer among patients reported PROMs among those who were not (88.4% vs. 79.5% after 18 months of follow-up; stratified HR, 2.30; 95% CI, 1.25–4.22; p = 0.007).
Sankey plot representing adverse events (AEs) reported at any category from PRO-CTCAE questionnaire 1 month, 3 months and 6 months after beginning antitumoral treatment.”
Title: Effects of an Electronic Patient Reported Outcome Measures (e-PROMs) Program on Symptom Reporting, Use of Healthcare, and Overall Survival in Patients With Lymphoma: A Multicenter Prospective Study
Authors: Raúl Córdoba, Marta del Olmo Rodríguez, Sergio Ramos, Alberto López García, Daniel Morillo, Maria-Angeles Pérez-Sáenz, Carolina Miranda, Rafael Martos, Laura Beltrán, Eva Castillo, Antonio Herrero, Alvaro Gómez-Meana, Bernadette Pfang, Jorge Short Apellaniz, Javier Arcos-Campillo
Read The Full Article at eJHaem.
More posts featuring Raul Cordoba.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023